en · de · es · pt
melanotan-2-notes.peptides3626.com › Topic › Chemistry And Receptor Pharmacology — Evidence Review

Chemistry And Receptor Pharmacology — Evidence Review

By Editorial Desk · published 2026-07-31 · last reviewed 2026-08-01 · Topic

lyophilised powder raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.

Reviewed 2026-08-01. Anything still debated is marked as such rather than presented as settled.

Chemistry and Receptor Pharmacology

Published pharmacokinetic information is limited and comes mainly from small studies rather than registrational trials. Plasma half-life is usually described as short, on the order of tens of minutes, followed by rapid tissue distribution and clearance of the intact peptide. Metabolites and low concentrations of parent compound have been reported in urine, a detail relevant to anti-doping and forensic testing. Whether repeated exposure changes receptor sensitivity or clearance over time remains an open question. Values differ noticeably between analytical assays, so published numbers should be read as approximate rather than definitive.

Melanotan II is a synthetic cyclic heptapeptide with the sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, corresponding to a molecular formula of C50H69N15O9 and a monoisotopic mass near 1024 daltons. It was designed as a structural analogue of alpha-melanocyte-stimulating hormone, a peptide hormone produced by cleavage of proopiomelanocortin. A lactam bridge between the aspartate and lysine side chains closes the ring, and the C-terminal amide removes a free carboxyl group. Both modifications increase resistance to enzymatic degradation compared with the linear parent hormone. Four substitutions distinguish it from afamelanotide, the linear analogue studied under the name melanotan I.

Receptor-binding studies classify melanotan II as a non-selective melanocortin agonist. It interacts with MC1R, MC3R, MC4R and MC5R, with reported affinities in the low nanomolar range and no strong subtype preference. Activation of MC1R on dermal melanocytes shifts pigment synthesis toward eumelanin, the dark polymer deposited in melanosomes and transferred to keratinocytes. Because the same peptide engages MC4R in the hypothalamus, it also appears in animal work on food intake and erectile response, which is why it is discussed in both pigment and metabolic research. Which receptor populations dominate after systemic exposure in humans is not fully established.

Handling, Storage and Analytical Control

Routine characterisation relies on reversed-phase high-performance liquid chromatography with ultraviolet detection near 214 nanometres, using a C18 column and a water-acetonitrile gradient containing trifluoroacetic acid. Electrospray ionisation mass spectrometry confirms the expected molecular mass and can reveal truncated or oxidised by-products that co-elute poorly. Sequence and stereochemistry require additional work, such as peptide mapping or amino acid analysis, because a chromatographic purity figure alone does not distinguish a diastereomer from the target peptide. Independent testing of research-grade material frequently shows measured content below the stated label, so a certificate of analysis is best read together with the method that produced it.

Melanotan-2 is handled in the laboratory as a lyophilised powder that dissolves readily in water, dimethyl sulfoxide and dimethylformamide, with limited solubility in ethanol. Stock solutions prepared in an organic solvent often precipitate when diluted into aqueous buffer, so gradual dilution with mixing is standard practice. The peptide carries a tryptophan residue and a histidine residue, both sensitive to oxidation and to alkaline conditions. Working solutions are therefore kept near neutral to slightly acidic pH, protected from light, and consumed within the same working session whenever that is practical.

Melanotan-2 at a glance

PropertyValueNotes
Molecular formulaC50H69N15O9Cyclic heptapeptide, C-terminally amidated
Approximate molecular mass1024 DaMonoisotopic mass of the free peptide
AppearanceWhite to off-white powderTypically supplied as a lyophilised solid
Solubility classSoluble in water and polar solventsAlso dissolves in neutral aqueous buffer
Common synonymsMelanotan II, MT-II, MT-2Described as a melanocortin agonist in early literature

Melanotan II Background and Mechanism

Receptor binding at MC1R on melanocytes raises intracellular cyclic AMP and increases expression of tyrosinase and related enzymes. The downstream result is greater synthesis of eumelanin, the dark pigment, without ultraviolet exposure acting as the trigger. The compound is not selective, however, and also engages MC3R, MC4R and MC5R, which are expressed in the central nervous system and elsewhere. That lack of selectivity is the explanation usually offered for effects reported outside pigmentation, including appetite suppression and nausea. Selectivity remains a central theme in comparative studies of related peptides.

Human data remain limited and mostly short-term. Reports describe small trials and observational accounts rather than large controlled studies, so questions about dose-response relationships and long-term effects on melanocytes stay open. Whether repeated exposure alters naevus behaviour is not settled in the published record. Researchers also note that self-administered use outside clinical settings makes actual exposure difficult to quantify. Statements about efficacy and safety should therefore be read as preliminary rather than established.

Melanotan II is a synthetic cyclic heptapeptide that acts as an agonist at melanocortin receptors. It was designed as a structural analogue of alpha-melanocyte-stimulating hormone, the endogenous peptide involved in pigment production. The analogue carries a lactam bridge that constrains the ring and slows enzymatic breakdown relative to the native hormone. In research literature it appears under several abbreviations, and naming conventions are not fully standardized. Published descriptions usually place it within the broader melanocortin agonist family.

Related pages on this site

Storage, Verification and Regulatory Status

Melanotan-2 appears on the World Anti-Doping Agency prohibited list within the peptide hormone class, and several national regulators treat it as an unapproved prescription substance. Some countries restrict importation or sale for personal use. Because the compound is widely traded as a research chemical, the practical legal picture differs between jurisdictions and shifts over time. Human safety data covering long periods are limited, and whether repeated pigmentation changes carry any lasting risk to melanocytes remains an open question.

Freeze-dried melanotan-2 is normally kept as a desiccated powder at minus twenty degrees Celsius or lower, shielded from light and moisture. Peptides of this size degrade through hydrolysis, oxidation and deamidation, and each pathway accelerates as temperature and water activity rise. Repeated freeze-thaw cycles promote aggregation and loss of material, so aliquoting a stock solution before freezing is standard laboratory practice. Once dissolved, the solution is markedly less stable than the powder. In laboratory work, solutions are generally refrigerated and used within days rather than kept for months.

Further detail

aminoglycosides (gentamicin, amikacin, tobramycin, but not kanamycin) quinolones (ciprofloxacin, levofloxacin, but not moxifloxacin) cephalosporins (ceftazidime, cefepime, cefoperazone, cefpirome, ceftobiprole, but not cefuroxime, cefotaxime, or ceftriaxone) antipseudomonal penicillins: carboxypenicillins (carbenicillin and ticarcillin), and ureidopenicillins (mezlocillin, azlocillin, and piperacillin). P. aeruginosa is intrinsically resistant to all other penicillins. carbapenems (meropenem, imipenem, doripenem, but not ertapenem) polymyxins (polymyxin B and colistin) monobactams (aztreonam) As fluoroquinolones are one of the few antibiotic classes widely effective against P. aeruginosa, in some hospitals, their use is severely restricted to avoid the development of resistant strains. On the rare occasions where infection is superficial and limited (for example, ear infections or nail infections), topical gentamicin or colistin may be used. For pseudomonal wound infections, acetic acid with concentrations from 0.5% to 5% can be an effective bacteriostatic agent in eliminating the bacteria from the wound. Usually a sterile gauze soaked with acetic acid is placed on the wound after irrigation with normal saline. Dressing would be done once per day. Pseudomonas is usually eliminated in 90% of the cases after 10 to 14 days of treatment.

=== Pharmacokinetics === Gepotidacin is rapidly absorbed orally, reaching peak plasma concentrations (tmax) after approximately 2.0 hours. In adults with uncomplicated urinary tract infections (uUTI) and normal renal function, the mean steady-state maximum concentration (Cmax) is 4.2 mcg/mL, and the area under the concentration-time curve over 12 hours AUC(0-12) is 22.8 mcg*hour/mL following a 1500 mg dose every 12 hours. Systemic exposure (Cmax and AUC) increases proportionally with dose. Accumulation of approximately 40% occurs and achieves a steady state by day 3. The absolute bioavailability is about 45%, and standard and moderate fat meals did not significantly affect its absorption. Gepotidacin's pharmacokinetics were found to be generally consistent across different ages, sexes, races, and body weights during modeling and simulation. Gepotidacin has a mean steady-state volume of distribution (Vss) of 172.9 liters and is 25-41% bound to plasma proteins. It has a terminal elimination half-life of approximately 9.3 hours and a total clearance of 33.4 L/hour. The primary metabolic pathway involves CYP3A4, with a minor metabolite (M4, ~11% of circulating drug). The co-administration of other drugs can influence gepotidacin levels. Strong inhibitors of CYP3A4 can increase gepotidacin exposure, whereas strong inducers of CYP3A4 can decrease it. Additionally, gepotidacin, at high concentrations, has shown the potential to increase the exposure of certain other drugs, including digoxin and midazolam.

Static light scattering and dynamic light scattering use light to determine the average molecular weight and behavior of the copolymer in solution whereas small-angle neutron scattering uses neutrons to determine the molecular weight and chain length. Additionally, x-ray scattering techniques, such as small-angle X-ray scattering (SAXS) can help determine the nanometer morphology and characteristic feature size of a microphase-separated block-copolymer or suspended micelles. Differential scanning calorimetry is a thermoanalytical technique used to determine the thermal events of the copolymer as a function of temperature. It can indicate when the copolymer is undergoing a phase transition, such as crystallization or melting, by measuring the heat flow required to maintain the material and a reference at a constantly increasing temperature. Thermogravimetric analysis is another thermoanalytical technique used to access the thermal stability of the copolymer as a function of temperature. This provides information on any changes to the physicochemical properties, such as phase transitions, thermal decompositions, and redox reactions. Size-exclusion chromatography can separate copolymers with different molecular weights based on their hydrodynamic volume. From there, the molecular weight can be determined by deriving the relationship from its hydrodynamic volume. Larger copolymers tend to elute first as they do not interact with the column as much.

HHV-6 re-activation causes severe disease in transplant recipients and can lead to graft rejection, often in consort with other betaherpesviruses. Likewise in HIV/AIDS, HHV-6 re-activations cause disseminated infections leading to end organ disease and death. Although up to 100% of the population are exposed (seropositive) to HHV-6, most by 3 years of age, there are rare cases of primary infections in adults. In the United States, these have been linked more with HHV-6a, which is thought to be more pathogenic and more neurotropic and has been linked to several central nervous system-related disorders. HHV-6 has been reported in multiple sclerosis patients and has been implicated as a co-factor in several other diseases, including chronic fatigue syndrome, AIDS, and temporal lobe epilepsy.

deoxyribonucleotide A nucleotide containing deoxyribose as its pentose sugar component, and the monomer or subunit used to build deoxyribonucleic acid (DNA) molecules. Deoxyribonucleotides canonically incorporate any of four nitrogenous bases: adenine (A), guanine (G), cytosine (C), and thymine (T). Compare ribonucleotide.

Sources: en.wikipedia.org

Supporting material

The group takes its name from Mighei (Ukraine), but the most famous member is the extensively studied Murchison meteorite. Many falls of this type have been observed and CM chondrites are known to contain a rich mix of complex organic compounds such as amino-acids and purine/pyrimidine nucleobases. CM chondrite famous falls:

The process continues until the rate of release of new electrons in collisions is balanced by the rate of recombination of electrons with argon ions (atoms that have lost an electron). This produces a ‘fireball’ that consists mostly of argon atoms with a rather small fraction of free electrons and argon ions.

Absence of antibodies in patients with diagnoses of an autoimmune thyroid in their past would always be suspicious for development to SAT even in the presence of a normal TSH because there is no known recovery from autoimmunity. For clinical interpretation of laboratory results it is important to acknowledge that TSH is released in a pulsatile manner resulting in both circadian and ultradian rhythms of its serum concentrations.

The birth of most Mexican drug cartels is traced to former Mexican Judicial Federal Police agent Miguel Ángel Félix Gallardo (Spanish: El Padrino, lit. 'The Godfather'), who founded the Guadalajara Cartel in 1980 and controlled most of the illegal drug trade in Mexico and the trafficking corridors across the Mexico–U.S. border along with Juan García Ábrego throughout the 1980s. He started by smuggling marijuana and opium into the U.S., and was the first Mexican drug chief to link up with Colombia's cocaine cartels in the 1980s. Through his connections, Félix Gallardo became the person at the forefront of the Medellín Cartel, which was run by Pablo Escobar. This was accomplished because Félix Gallardo had already established a marijuana trafficking infrastructure that stood ready to serve the Colombia-based cocaine traffickers. There were no other cartels at that time in Mexico. He oversaw operations with his cronies and the politicians who sold him protection. The Guadalajara Cartel suffered a major blow in 1985 when the group's co-founder Rafael Caro Quintero was captured, and later convicted, for the murder of DEA agent Enrique "Kiki" Camarena. Félix Gallardo then kept a low profile and in 1987 he moved with his family to Guadalajara. According to Peter Dale Scott, the Guadalajara Cartel prospered largely because it enjoyed the protection of the Dirección Federal de Seguridad (DFS), under its chief Miguel Nazar Haro. Félix Gallardo was arrested on April 8, 1989.

Sources: en.wikipedia.org

Notes from published material

== Treatment == Treatment for Ullrich congenital muscular dystrophy can consist of physical therapy and regular stretching to prevent and reduce contractures. Respiratory support may be needed at some point by the affected individual. Non-invasive ventilation (NIV), typically in the form of bilevel positive airway pressure (BiPAP), is the most commonly used form of respiratory support, with ventilation via a tracheostomy used in some cases. While primary cardiomyopathy is not a typical feature of this type of CMD, chronic respiratory insufficiency can lead to secondary right heart strain, which NIV also helps to prevent.

=== Drug dependence === Gabapentin is moderately effective in reducing the symptoms of alcohol withdrawal and associated craving. The evidence in favor of gabapentin is weak in the treatment of alcoholism: it does not contribute to the achievement of abstinence, and the data on the relapse of heavy drinking and percent of days abstinent do not robustly favor gabapentin; it only decreases the percent days of heavy drinking. Gabapentin is ineffective in cocaine dependence and methamphetamine use, and it does not increase the rate of smoking cessation. While some studies indicate that gabapentin does not significantly reduce the symptoms of opiate withdrawal, there is increasing evidence that gabapentinoids are effective in controlling some of the symptoms during opiate detoxification. A clinical study in Iran, where heroin dependence is a significant social and public health problem, showed gabapentin produced positive results during an inpatient therapy program, particularly by reducing opioid-induced hyperalgesia and drug craving. There is insufficient evidence for its use in cannabis dependence.

During the recording of A Loner, Chanut used an old Marshall JMP head to add more upper mids, giving the sound a more defined character. To get a "really fat sound" in the studio, he used his Rivera electric guitar amplifier, the brand's first generation. For the electric guitar parts, the band wanted a "bright sound" with less gain and "to remove this flattering aspect" of the sub-bass characteristic of doom or sludge metal. To "let the music breathe more" and to highlight the guitar effects, particularly the reverbs, Thépegnier decided to "lighten" his drumming. Thépegnier further stated that they wanted to "lighten" their sound and achieve this "bright" result that would enable them to embrace "our cold ambiences even more. Getting out of our 'doomy' comfort zone". Journalist Jean-Charles Desgroux wrote that the band "dares to experiment" on A Loner and "beyond doom, sludge or at worst that muddy stoner which they will never claim". David wrote in his review of A Loner: "The French group experiments, plays with effects, textures and nuances". At this stage of their musical evolution, they demonstrated a greater presence of melodies and introspection and were sometimes more atmospheric. While Hangman's Chair blended various doom sounds to create an atmosphere on This Is Not Supposed To Be Positive, they sounded, on A Loner, like a different band from their earlier work, with gothic sounds closer to goth rock and cold wave than metal at this stage. The "stoner band" they had been in the past had nevertheless left some "artefacts" in their music.

== Books == Johann Hari (2002). God Save the Queen?. Icon Books. ISBN 978-1-84046-401-6. Johann Hari (2015). Chasing the Scream: The First and Last Days of the War on Drugs. Bloomsbury. ISBN 978-1-62040-890-2. Johann Hari (2018). Lost Connections: Uncovering the Real Causes of Depression – and the Unexpected Solutions. Bloomsbury. ISBN 978-1-63286-830-5. Johann Hari (2021). Stolen Focus: Why You Can't Pay Attention. Bloomsbury. ISBN 978-1-5266-2022-4. Johann Hari (2024). Magic Pill: The Extraordinary Benefits and Disturbing Risks of the New Weight Loss Drugs. Bloomsbury. ISBN 978-1-52667015 {{isbn}}: Check isbn value: length (help).

Their feature documentary Kumu Hina, about transgender native Hawaiian teacher and cultural icon Hinaleimoana Wong-Kalu, was supported by ITVS, Pacific Islanders in Communications and the Ford Foundation and won the GLAAD Media Award for Outstanding Documentary and the Independent Lens Audience Award on PBS In 2017, Hamer and Wilson, with Hinaleimoana Wong-Kalu as producer, released Leitis in Waiting and Lady Eva, which documented the lives of transgender women in the conservative South Pacific Kingdom of Tonga. This was followed in 2019 by The Rogers, about transgender men in Samoa. These films became part of a campaign to decriminalize same-sex relationships across the Pacific. Hamer, Wilson and Wong-Kalu continued their collaboration in 2020 with the animated short film Kapaemahu, based on the hidden history of four stones on Waikiki Beach placed there as a tribute to four legendary mahu who first brought the healing arts from Tahiti to Hawaii. It premiered and won the Special Jury Prize at the Tribeca Film Festival and was shortlisted for an Oscar as Best Animated Short Film at the 93rd Academy Awards. The animated film was followed by a children's book published by Kokila, a PBS feature documentary, a multimedia exhibition at the Bishop Museum, permanent display at the Hawaiʻi Convention center, and inclusion in new interpretative signage at the Kapaemahu monument in Waikiki. The team's most recent film is Aikane, an animated short based on the Hawaiian term for intimate friends of the same sex.

Sources: en.wikipedia.org

Frequently asked questions

Is melanotan II identical to alpha-melanocyte-stimulating hormone?

No. It is a synthetic analogue carrying four amino acid changes, a lactam ring and an amidated C-terminus. The natural hormone is a linear thirteen-amino-acid peptide processed from proopiomelanocortin.

How does melanotan II differ from afamelanotide?

Afamelanotide is the linear analogue [Nle4-D-Phe7]-alpha-MSH, sometimes called melanotan I, while melanotan II is cyclic and carries three further substitutions. The two are distinct molecules and are not interchangeable in analytical testing.

Is the receptor binding profile well established?

Binding to the four melanocortin receptor subtypes is well documented in vitro. The relative contribution of each subtype to whole-body effects in humans is far less certain.

How is peptide purity usually reported?

Purity is normally stated as an area percentage from high-performance liquid chromatography, for example ninety-five or ninety-eight percent. That figure describes the proportion of ultraviolet-absorbing material eluting as the main peak. It says nothing about water content, counterions, residual solvents or mass fraction of the peptide itself.

Network